Amnion Membrane Powder Mohs Study

Part of paid clinical trials in Winston-Salem, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT07680023
Phase
PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Wound Heal

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Amnion Membrane Powder — DRUG
    amnion membrane power dose of 0.26 mg/mm3 applied during MOHS scalp surgery
  • Standard of Care — DRUG
    aquaphor ointment applied during MOHS scalp surgery

Study Details

The purpose of this research study is to test the safety of the amnion membrane powder to see if it improves wound healing in patients undergoing Mohs surgery on the scalp.

Key Dates

Start date
Oct 31, 2026
Status verified
Jun 2026
Primary completion
Oct 31, 2027
Completion
Oct 31, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Amnion Membrane Powder
    amnion membrane power applied during MOHS scalp surgery
  • Active Comparator: Standard of Care
    aquaphor ointment applied during MOHS scalp surgery

Primary Outcome Measure

Number of Participants with Infection [ Time Frame: Through week 16 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Atrium Health Wake Forest BaptistWinston-SalemNorth Carolina27157
Mary-Clare Day
336-713-1343

Find similar trials in Winston-Salem, NC

Related Studies